Agonist-specific impairment of coronary vascular function in genetically altered, hyperlipidemic mice

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 276, Issue 4 45-4, 1999, Pages

  Lamping, Kathryn G ^a,b   Nuno, Daniel W ^a   Chappell, David A ^a   Faraci, Frank M ^a  

^a UNIVERSITY OF IOWA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Acetylcholine; Coronary artery; Endothelium; Gene targeted mice; Nitric oxide; Serotonin; Soluble guanylate cyclase

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; ACETYLCHOLINE; APOLIPOPROTEIN E; GUANYLATE CYCLASE; LOW DENSITY LIPOPROTEIN RECEPTOR; N(G) NITROARGININE; NITROPRUSSIDE SODIUM; PAPAVERINE; SEROTONIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL INTAKE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; ENDOTHELIUM CELL; GENETIC SUSCEPTIBILITY; HYPERLIPIDEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; VASODILATATION;

EID: 0032929229     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1999.276.4.r1023     Document Type: Article

References (39)

1. Bonthu, S., D. D. Heistad, D. A. Chappell, K. G. Lamping, and F. M. Faraci. Atherosclerosis, vascular remodeling, and impairment of endothelium-dependent relaxation in genetically altered hyperlipidemic mice. Arterioscler. Thromb. Vasc. Biol. 17: 2333-2340, 1997.
2. Breslow, J. L. Mouse models of atherosclerosis. Science 272: 685-688, 1996.
3. Brown, M. S., J. R. Faust, and J. L. Goldstein. Role of the low density lipoprotein receptor in regulating the content of free and esterified cholesterol in human fibroblasts. J. Clin. Invest. 55: 783-793, 1975.
4. De Silva, H. V., J. Mas-Oliva, J. M. Taylor, and R. W. Mahley. Identification of apolipoprotein B-100 low density lipoproteins, apolipoprotein B-48 remnants, and apolipoprotein E-rich high density lipoproteins in the mouse. J. Lipid Res. 35: 1297-1310, 1994.
5. Egashira, K., Y. Katsuda, M. Mohri, T. Kuga, T. Tagawa, T. Kubota, Y. Hirakawa, and A. Takeshita. Role of endothelium-derived nitric oxide in coronary vasodilatation induced by pacing tachycardia in humans. Circ. Res. 79: 331-335, 1996.
6. Faraci, F. M., C. D. Sigmund, E. G. Shesely, N. Maeda, and D. D. Heistad. Responses of carotid artery in mice deficient in expression of the gene for endothelial NO synthase. Am. J. Physiol. 274 (Heart Circ. Physiol. 43): H564-H570, 1998.
7. Feletou, M., and P. M. Vanhoutte. Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br. J. Pharmacol. 93: 515-524, 1988.
8. Flavahan, N. A., H. Shimokawa, and P. M. Vanhoutte. Pertussis toxin inhibits endothelium-dependent relaxations to certain agonists in porcine coronary arteries. J. Physiol. (Lond.) 408: 549-560, 1989.
9. Forstermann, U., A. Mulsch, E. Bohme, and R. Busse. Stimulation of soluble guanylate cyclase by an acetylcholine-induced endothelium-derived factor from rabbit and canine arteries. Circ. Res. 58: 531-538, 1986.
10. Freiman, P. C., G. G. Mitchell, D. D. Heistad, M. L. Armstrong, and D. G. Harrison. Atherosclerosis impairs endothelium-dependent vascular relaxation to acetylcholine and thrombin in primates. Circ. Res. 58: 783-789, 1986.
11. Galle, J., A. Mulsch, R. Busse, and E. Bassenge. The effects of native and oxidized low-density lipoproteins on the formation and inactivation of endothelium-derived relaxing factor. Arterioscler. Thromb. 11: 198-203, 1991.
12. Ghiselli, G. E., E. J. Schaefer, P. Gascon, and H. B. Brewer. Type III hyperlipidemia associated with apolipoprotein E deficiency. Science 214: 1239-1241, 1981.
13. Heistad, D. D., M. L. Armstrong, M. L. Marcus, D. J. Piegors, and A. L. Mark. Augmented responses to vasoconstrictor stimuli in hypercholesterolemic and atherosclerotic monkeys. Circ. Res. 54: 711-718, 1984.
14. Henry, P. D., and M. Yokoyama. Supersensitivity of atherosclerotic rabbit aorta to ergonovine. J. Clin. Invest. 66: 306-313, 1980.
15. Ishibashi, S., J. Herz, N. Maeda, J. L. Goldstein, and M. S. Brown. The two-receptor model of lipoprotein clearance: test of the hypothesis in "knockout" mice lacking the low density lipoprotein receptor, apolipoprotein E or both proteins. Proc. Natl. Acad. Sci. USA 91: 4431-4435, 1994.
16. Jacobs, M., F. Plane, and K. R. Bruckdorfer. Native and oxidized LDL have different inhibitory effects on endothelium derived relaxing factor in the rabbit aorta. Br. J. Pharmacol. 100: 21-26, 1990.
17. Kuga, T., M. Mohri, K. Egashira, Y. Hirakawa, T. Tagawa, H. Shimokawa, and A. Takeshita. Bradykinin-induced vasodilation of human coronary arteries in vivo: role of nitric oxide and angiotensin-converting enzyme. J. Am. Coll. Cardiol. 30: 108-112, 1997.
18. Kugiyama, K., S. A. Kerns, J. D. Morrisett, R. Roberts, and P. D. Henry. Impairment of endothelium dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature 344: 160-162, 1990.
19. Lamontagne, D., A. Konig, E. Bassenge, and R. Busse. Prostacyclin and nitric oxide contribute to the vasodilator action of acetylcholine and bradykinin in the intact rabbit coronary bed. J. Cardiovasc. Pharmacol. 20: 652-657, 1992.
20. Liao, J. K., M. A. Bettmann, T. Sandor, J. I. Tucker, S. M. Coleman, and M. A. Creager. Differential impairment of vasodilator responsiveness of peripheral resistance and conduit vessels in humans with atherosclerosis. Circ. Res. 68: 1027-1034, 1991.
21. Mahley, R. W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240: 622-630, 1988.
22. Minor, R. L., P. R. Myers, R. Guerra, J. N. Bates, and D. H. Harrison. Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J. Clin. Invest. 86: 2109-2116, 1990.
23. Mugge, A., J. H. Elwell, T. E. Peterson, and D. G. Harrison. Release of intact endothelium-derived relaxing factor depends on endothelial superoxide dismutase activity. Am. J. Physiol. 260 (Cell Physiol. 29): C219-C225, 1991.
24. Mugge, A., J. H. Elwell, T. E. Peterson, T. G. Hofmeyer, D. D. Heistad, and D. H. Harrison. Chronic treatment with polyethylene-glycolated superoxide dismutase partially restores endothelium-dependent vascular relaxations in cholesterol-fed rabbits. Circ. Res. 69: 1293-1300, 1991.
25. Nakashima, Y., A. S. Plump, E. W. Raines, J. L. Breslow, and R. Ross. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler. Thromb. 14: 133-140, 1994.
26. Napoli, C., R. Paterno, F. M. Faraci, H. Taguchi, A. Postiglione, and D. D. Heistad. Mildly oxidized low-density lipoprotein impairs responses of carotid but not basilar artery in rabbits. Stroke 28: 2266-2272, 1997.
27. q/11. Mol. Pharmacol. 45: 890-898, 1994.
28. Olesen, S. P., J. Drejer, O. Axelsson, P. Moldt, L. Bnag, J. E. Nielsen-Kudsk, R. Busse, and A. Mulsch. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase. Br. J. Pharmacol. 123: 299-309, 1998.
29. Palmer, R. M. J., A. G. Ferrige, and S. Moncada. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-525, 1987.
30. Panza, J. A., P. R. Casino, C. M. Kilcoyne, and A. A. Quyyumi. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 87: 1468-1474, 1993.
31. Plump, A. S., J. D. Smith, T. Hayek, K. Aalto-Serala, A. Walsh, J. G. Verstuyft, E. M. Rubin, and J. L. Breslow. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71: 343-353, 1992.
32. Reddick, R. L., S. H. Zhang, and N. Maeda. Atherosclerosis in mice lacking apo E: evaluation of lesional development and progression. Arterioscler. Thromb. 14: 141-147, 1994.
33. Shimokawa, H., N. A. Flavahan, and P. M. Vanhoutte. Loss of endothelial pertussis toxin-sensitive G protein in atherosclerotic porcine coronary arteries. Circulation 83: 652-660, 1991.
34. Shimokawa, H., H. Tomoike, S. Nabeyama, H. Yamamoto, H. Araki, M. Nakamura, Y. Ishii, and K. Tanaka. Coronary artery spasm induced in atherosclerotic miniature swine. Science 221: 560-561, 1983.
35. Sobey, C. G., and F. M. Faraci. Effects of a novel inhibitor of guanylate cyclase on dilator responses of mouse cerebral arterioles. Stroke 28: 837-843, 1997.
36. Tagawa, H., H. Tomoike, and M. Nakamura. Putative mechanisms of the impairment of endothelium-dependent relaxation of the aorta with atheromatous plaque in heritable hyperlipidemic rabbits. Circ. Res. 68: 330-337, 1991.
37. Taguchi, H., F. M. Faraci, T. Kitazono, and D. D. Heistad. Relaxation of the carotid artery to hypoxia is impaired in Watanabe heritable hyperlipidemic rabbits. Arterioscler. Thromb. Vasc. Biol. 15: 1641-1645, 1995.
38. Tangirala, R. K., E. M. Rubin, and W. Palinski. Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. J. Lipid Res. 36: 2320-2328, 1995.
39. Zhang, S. H., R. L. Reddick, J. A. Piedrahita, and N. Maeda. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258: 468-471, 1992.